Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes. [electronic resource]
Producer: 20010308Description: 13-7 p. digitalISSN:- 0143-5221
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.